Don’t let the heatwave affect your medicines: Three important tips from the MHRA

The Commission on Human Medicines (CHM) has endorsed changes to the risk minimisation measures for isotretinoin, following a review of the impact of the measures implemented in 2023. We ask healthcare professionals to review these new measures and supporting materials and integrate them into their clinical practice.

How to get information including patient information leaflets (PILs), details on how the medicine can be used (SmPCs) and scientific reports (PARs).

How to apply for a regulatory advice meeting on medical devices and in vitro diagnostic devices.

More than 40 people hospitalised following suspected use of unlicensed botulinum toxin products.

Patients to benefit from new era in cancer treatment, as Government slashes red tape to unleash life-saving innovation

Nearly 20 million doses of potentially dangerous medicines prevented from reaching the public